Objective: To evaluate the frequency, severity, distress, and correlates of common and rare symptoms reported by nulliparous women during the last month of pregnancy.
common symptoms such as fatigue, insomnia, nausea, constipation, or back pain and how these symptoms change during the course of pregnancy (Beebe & Lee, 2007; Chou, Kuo, & Wang, 2008; Hall et al., 2012; K. A. Lee, Zaffke, & McEnany, 2000) , the multidimensional nature of a wider variety of symptoms experienced during late pregnancy has not been described for healthy women pregnant with their first children.
The framework for this study was grounded in the Theory of Symptom Management in which the dimensions of symptom experience include its perceived frequency, severity, and distress, as well as the self-management and medical management strategies used to reduce adverse outcomes (Dodd et al., 2001; Humphreys et al., 2014; see Figure 1 ). In this model, symptom experience does not occur in a vacuum but interacts with a number of factors, including personal characteristics, the environment, and a person's state of health. During pregnancy, prior experience, education, ethnicity, age, gestational weight gain, and other factors can contribute to the perception and appraisal of symptoms. The purpose of this study was to describe the prevalence, frequency, and severity of symptoms; distress; and correlates of common and rare symptoms reported by nulliparous women during the last month of pregnancy. For the purpose of this study, common symptoms were defined as subjectively perceived experiences reflecting changes in sensations of an individual and reported to occur in a common or expected way during pregnancy (Dodd et al., 2001) . From these findings, priorities for future research and clinical guidelines for interventions can be formulated.
Methods
This study was approved by the institution's Committee on Human Research. As part of a larger randomized clinical trial to test an intervention to improve sleep during the first 3 months after birth, expectant women were recruited between 2004 and 2008 from free childbirth education classes and low-income antepartum clinics that serve the diverse population in the San Francisco Bay Area (K. A. Lee & Gay, 2011) . Eligible participants included women expecting their first children, at least 18 years of age, at least 36 weeks gestation with singleton pregnancies, at low risk for adverse pregnancy outcomes, and able to read and write English. Because of the postpartum sleep-related clinical trial, women were excluded if they worked night shifts; had diagnosed sleep or mood disorders; or were taking medication for pain, sleep, or psychiatric problems. Of the 32 symptoms examined, participants reported an average of 10. 6 ± 5.6 (range [ 0-24) , but most were not frequent, severe, or distressful.
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After informed consent was obtained, participants were scheduled for home visits at or after 36 weeks gestation to obtain baseline symptom data during the last month of pregnancy. Weightrelated information was collected at postpartum assessments (3-6 weeks after birth). All participants were paid for their participation. This study was a cross-sectional secondary analysis of selfreported demographic and symptom data collected from the participants during the last month of pregnancy before the intervention was introduced.
Measures
Self-report questionnaires were used to collect data about participant characteristics; their general symptom experience during the past week; and their specific experiences of sleep disturbance, depression, and anxiety symptoms during the past week.
Participant Characteristics
Women in the last month of pregnancy provided demographic information about their personal characteristics of age, race/ethnicity, years of education, marital/partner status, employment status, income, pregnancy history, and plans for infant feeding and infant care after birth. During an early postpartum home visit (within 3-6 weeks), participants also indicated their height and weight before pregnancy and their weight measured at their final prenatal appointment. Prepregnancy and late pregnancy body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Prepregnancy BMI was categorized as underweight (<18.5 kg/m 2 ), normal weight (18.5-24.9 kg/m 2 ), overweight (25-29.9 kg/m 2 ), or obese ($30 kg/m 2 ). Gestational weight gain was quantified as the number of pounds gained (or lost) during the pregnancy (calculated as prepregnancy weight subtracted from weight at most recent prenatal appointment) and categorized relative to the guidelines recommended by the Institute of Medicine (2009) based on prepregnancy BMI: (a) less than the recommended minimum, (b) within the recommended range, or (c) more than the recommended maximum. The percentage of weight gain more than the recommended maximum was also calculated.
General Symptom Experience
The Memorial Symptom Assessment Scale (MSAS) was used to assess participants' general symptom experience during the past week (Portenoy et al., 1994) . The MSAS evaluates 24 symptoms on dimensions of any occurrence (yes or no), frequency and severity (1-4 Likert scales), and distress (0-4 Likert scale). An individual score for each symptom is computed as the average score on the severity, frequency, and distress dimensions. If the participant does not report the symptom, the individual symptom score is 0. There are eight additional symptoms evaluated only on the severity and distress dimensions, such as hair loss and weight loss, because they are unlikely to vary in frequency over a 1-week time frame. Based on these 32 individual items, four validated MSAS summary measures are calculated: (a) the number of endorsed items from the list of 32 possible symptoms (total symptom count range ¼ 0-32), (b) the average of the 6 psychological symptom scores (psychological subscore range ¼ 0-4), (c) the average score for 12 prevalent physical symptoms (physical subscore range ¼ 0-4), and (d) the total score (range ¼ 0-4) obtained by averaging the individual symptom scores. Detailed scoring instructions have been previously published (Portenoy et al., 1994) . Cronbach alpha coefficients in this sample were 0.85 for the total symptom count, 0.88 for the total score, 0.83 for the psychological subscore, and 0.69 for the physical subscore.
In addition, there is space after these 32 symptoms for participants to add any "other" symptoms. Because of the known increased prevalence of insomnia (K. A. Lee et al., 2000) and restless legs syndrome (Beebe & Lee, 2007; K. A. Lee, Zaffke, & Baratte-Beebe, 2001; Picchietti et al., 2015) during the course of pregnancy, we added seven items: four items to address specific criteria for restless legs syndrome (Garcia-Borreguero et al., 2011) and three specific dimensions of insomnia (difficulty falling asleep at bedtime, problems staying asleep during the night, and problems staying awake during the day). These symptoms were not considered in the computations of the MSAS summary scores.
The MSAS is a valid and reliable self-report measure of overall symptom experience that has been used in various clinical populations, particularly in chronic illnesses such as cancer and HIV infection (Blinderman, Homel, Billings, Portenoy, & Tennstedt, 2008; Sawicki, Sellers, & Robinson, 2008) . This instrument was specifically selected to elicit three dimensions of symptom experience (frequency, severity, and degree of distress) across a wide variety of physical and psychological perceptions. However, because to our knowledge this measure has not Symptom Experience been used to assess the symptom experience of pregnant women, standardized measures to assess specific symptoms related to sleep, depression, and anxiety during the past week were also included in this study for comparison with the MSAS measure.
Specific Sleep, Anxiety, and Depression Symptoms
Sleep disturbance. The General Sleep Disturbance Scale (GSDS) was used to specifically assess symptoms related to sleep quality and quantity during the previous week (K. A. Lee, 1992) . The GSDS has 21 items that evaluate various aspects of sleep. Each item is rated on a 0 (never) to 7 (every day) numeric rating scale. The 21 items are summed to yield a total score that could range from 0 (no disturbance) to 147 (extreme disturbance). A score of 3 or greater (i.e., 3 or more days per week) on any single item indicates a problem with sleep that should be assessed for potential intervention, and scores of 43 and greater indicate a clinically significant level of sleep disturbance. The GSDS has well-established validity and reliability in women (K. A. Lee, 1992) . In this study, the Cronbach alpha coefficient for the GSDS was 0.80.
Depression symptoms. The 20-item Center for Epidemiological Studies-Depression (CES-D) scale is widely used to screen for depression symptoms in the general population and in childbearing women (Radloff, 1977) . Respondents are asked to think about the past week and check the response that best describes how often they felt or behaved this way. Responses can range from 0 (rarely/none or 1 day) to 3 (most/all the time or 5-7 days). The total score ranges from 0 to 60, with a greater score representing more frequent depression symptoms. A score of 16 or greater is suggested as a risk factor for depression and need for clinical evaluation (Radloff, 1977) . In the current sample, the Cronbach alpha coefficient was 0.87 in the third trimester.
Anxiety. The Profile of Moods State (POMS) contains a Tension-Anxiety subscale (McNair, Lorr, & Droppleman, 1971 ) that was used to assess anxiety severity during the past week. The subscale has nine items selected to represent major symptoms of anxiety. Responses range from 0 (not at all) to 4 (extreme), and total scores can range from 0 to 36. The POMS has well-established concurrent and construct validity. In this study, the Cronbach alpha coefficient for the POMS subscale was 0.83.
Statistical Analysis
To simplify the symptom data for analysis, responses on the MSAS were recoded from the 4-point scale responses to dichotomous values for frequency (rare or occasional vs. frequent or almost constant) and severity (slight or moderate vs. severe or very severe). The 5-point scale for distress was also dichotomized (not at all, a little bit, or somewhat vs. quite a bit or very much). Dichotomization of MSAS dimension scores has been used in previous research to identify symptoms that are most frequent, severe, and distressing (Blinderman et al., 2008; Pettersson, Bertero, Unosson, & Borjeson, 2014) .
Frequencies and descriptive statistics were used to check for normality and to summarize demographic and clinical characteristics of the sample. Analysis of variance was used to compare symptom measures for different demographic groupings and for different clinical parameters. Pearson correlations (r) and Spearman correlations (r) were used when appropriate to assess the magnitude of association between symptom measures and continuous variables. Paired t tests were used to compare MSAS psychological and physical subscale scores. Two-tailed p values of .05 or less were considered statistically significant. The sample size was determined by the size of the randomized clinical trial for which the data were collected.
Results

Sample Characteristics
Of 198 women recruited, 152 were eligible and enrolled in the third trimester for the clinical trial, and 151 had complete data for analysis of symptoms during the last month of pregnancy. There were no differences in sociodemographic characteristics between participants and women who were not eligible to participate. Descriptive baseline data on this sample's characteristics are presented in Table 1 . This sample of first-time mothers was racially diverse and had predominantly low income (86%). There were nine (6%) who currently smoked and 23 (15%) who worked outside the home. Births occurred at three different hospital sites and at an average of 21 AE 11 days after these symptom data were collected. Most (69%) had a vaginal birth, infant
birth weight ranged from 2.1 to 4.9 kg, and 46% of the infants were girls. Of the 131 participants who had complete data for gestational weight gain, at approximately 36 weeks more than half (60%, n ¼ 78) had already gained more than the maximum weight recommended for their prepregnancy BMIs.
Symptom Prevalence
The 32 symptoms on the MSAS are listed in Table 2 according to their prevalence in this sample. From this list, participants experienced an average of 10.6 AE 5.6 symptoms (range ¼ 0-24). Although there was a strong positive correlation between the psychological and physical subscales of the MSAS (r ¼ 0.68, p < .001), the mean score for the psychological subscale (1.03 AE 0.83) was significantly greater than for the physical subscale (0.57 AE 0.41; t 149 ¼ 9.07, p < .001). The eight symptoms experienced by at least half of the sample included lack of energy, pain, difficulty sleeping, worrying, irritable, drowsy, shortness of breath, and nervous. Of the 32 symptoms on the MSAS, only six symptoms were reported by fewer than 10% of the sample (change in food tastes, vomiting, hair loss, weight loss, mouth sores, and difficulty swallowing). Although participants did add other symptoms to the list of 32 in the space provided for other symptoms, these additions could all be classified under the rubric of the general pain item, which they also endorsed. These other pain symptoms included back pain, abdominal discomfort, heartburn, and leg cramps.
Symptom Frequency
The frequency with which 24 symptoms were experienced is also reported in Table 2 . Difficulty sleeping was experienced frequently or almost constantly by half (51%) of the participants who reported they had the symptom, followed by 44% of those who experienced lack of energy or problems with sexual interest/activity. The fourth and fifth most frequent symptoms were numbness/tingling in hands/feet and problems with urination, with these symptoms reported by 40% of the participants.
Symptom Severity and Distress
The range of distress for each of the reported symptoms is shown in Figure 2 . Although lack of energy was experienced by 76% of the sample, it was not a particularly severe or distressful symptom. Among the eight most prevalent symptoms, difficulty sleeping was the most likely to be described as severe (37%) and distressful (33%) by those who reported it. Although less than 10% of the sample reported the occurrence of hair loss or mouth sores in the past week, these two symptoms were severe for 38% and 60% of the participants who experienced them, respectively, and distressful for 50% and 40%, respectively. 
Symptom Experience
In addition to hair loss, mouth sores, and difficulty sleeping, four other symptoms in the MSAS were rated as distressful for at least one third of the participants who experienced them: changes in skin (47%), constipation (38%), vomiting (38%) and change in body image or I don't look like myself (33%).
Additional Symptoms of Sleep Disturbance and Restless Legs
Other symptoms related to sleep disturbance and restless legs syndrome were also evident. The MSAS prevalence for difficulty sleeping (68%) was more similar to the added item about problems staying asleep (65%) than to the added items about problems falling asleep (47%) and staying awake during the day (35%). The frequency, severity, and distress ratings for these items were similar to the MSAS item about difficulty sleeping, yet helped to distinguish the type of sleeping difficulty being experienced. The MSAS prevalence of feeling drowsy (53%) was greater than the added item about problems staying awake during the day (35%). Although the MSAS item does not distinguish between drowsiness during the day or in the evening, problems staying awake during the day were somewhat more frequent, severe, and distressful than feeling drowsy (see Tables 2 and 3 ).
An abnormal sensation or urge to move one's legs was a distinct symptom from the MSAS symptom of numbness and tingling in arms/legs. Although the appearance of these symptoms caused equal distress for 26% of those who experienced them, numbness and tingling was more prevalent (48%) than abnormal sensation or urge to move legs (31%) or meeting all four criteria for restless legs syndrome (14%).
Associations Among the MSAS and Other Symptom Measures
The MSAS psychological subscale score was highly correlated with frequency of depression symptoms on the CES-D (r ¼ 0.713, p < .001), severity of anxiety symptoms on the POMS subscale (r ¼ 0.808, p < .001), and frequency of sleep disturbance on the GSDS (r ¼ 0.571, p < .001). Similar to the MSAS psychological subscale, the MSAS physical subscale score was also significantly correlated, but to a lesser degree, with depression symptoms on the CES-D (r ¼ 0.437, p < .001), anxiety on the POMS anxiety subscale (r ¼ 0.637, p < .001), and sleep disturbance on the GSDS (r ¼ 0.506, p < .001). The MSAS total score was also similarly correlated with these other symptom measures (CES-D: r ¼ 0.636, p < .001; POMS anxiety: r ¼ 0.781, p < .001; GSDS: r ¼ 0.581, p < .001).
Correlates of MSAS Symptom Experience
Symptom experience as measured by the MSAS was associated with few of the demographic and clinical characteristics in Table 1 . There was no relationship between MSAS summary scores and maternal age, employment, income, marital or partner status, number of days before birth, Beebe, K. R., Gay, C. L., Richoux, S. E., and Lee, K. A. prepregnancy BMI category, or newborn's sex or birth weight. However, among the participants with complete data on weight gain during pregnancy (n ¼ 131), MSAS total scores were significantly greater for the 78 participants who exceeded the recommended weight gain based on their prepregnancy BMIs compared with the 53 participants who gained the recommended weight or less than recommended (0.53 AE 0.37 vs. 0.67 AE 0.46; t 129 ¼ 2.00, p ¼ .047). In addition, the percentage of weight gained more than the recommended maximum was positively associated with MSAS total scores (r ¼ 0.229, p ¼ .008) and psychological subscores (r ¼ 0.237, p ¼ .006) but not with physical subscores (r ¼ 0.082, p ¼ .349).
Although the number of participants in some racial/ethnic groups was small, exploratory analyses suggested some significant racial/ ethnic differences in symptom experience. 
Discussion
Most pregnant women in the last month of pregnancy experience a number of psychological and physical symptoms with varying degrees of frequency, severity, and distress. Although scores on the MSAS psychological subscale were greater than on the physical subscale, there was a strong relationship between the physical and psychological subscales of the MSAS. Only 6 of the 32 symptoms assessed with the MSAS were experienced by fewer than 10% of the sample: change in food taste, vomiting, hair loss, weight loss, mouth sores, and difficulty swallowing. Although difficulty swallowing was rarely experienced, it was highly distressing and would warrant clinical evaluation and intervention. Symptoms with such a low prevalence should not be considered a normal experience in late pregnancy and should trigger clinical follow up. The most consistently prevalent and bothersome symptom in late pregnancy was difficulty sleeping, more specifically identified as problems staying asleep. Symptoms of sleep disturbances during the third trimester have been described in prior studies (Dorheim, Bjorvatn, & Eberhard-Gran, 2012; Izci et al., 2006; K. A. Lee & DeJoseph, 1992; Montgomery-Downs, Insana, Clegg-Kraynok, & Mancini, 2010) , yet this study is the first, to our knowledge, to report on a more comprehensive symptom experience in a sample of low-risk, nulliparous women. Symptom dimensions include not only presence or absence but also frequency, severity, and associated distress.
Prevalence of symptoms typically considered common and uncommon during the third trimester of pregnancy did not always show consistent patterns in this and other studies. Some symptoms, such as lack of energy and drowsiness, correspond to findings from a study on fatigue (Cheng et al., 2015) . Other symptoms, such as nausea, were still experienced by 1 in 4 (26%) participants during late pregnancy in our study, despite authors of prior studies who reported nausea and vomiting as quite common (up to 80%), but only in the early months of pregnancy (Chou et al., 2008) . Our findings, however, are consistent with those of other researchers who confirm the persistence of nausea Overall symptom experience was worse for women who exceeded recommended weight gain compared with women who gained the recommended amount or less.
Symptom Experience in the second (Kamysheva, Wertheim, Skouteris, Paxton, & Milgrom, 2009 ) and third (Herrero et al., 2001; Nazik & Eryilmaz, 2014) trimesters. It was also surprising that shortness of breath was endorsed by only half the sample (53%) when it is a common complaint during the third trimester where movement of the diaphragm is limited by the size of the fetus. Nazik and Eryilmaz (2014) found an even greater proportion (62.4%) of women in the third trimester who reported that they experienced breathing difficulty. This difference could be explained by how the symptom is worded or by the timing of data collection for women in late pregnancy. More participants in the current study may have experienced relief from this symptom if the fetus had descended into the pelvis in preparation for birth.
In this study, not all highly prevalent symptoms were rated as severe or highly distressing (e.g., feeling drowsy or nervous). Conversely, not all highly distressing symptoms were particularly common (e.g., hair loss or difficulty swallowing). Some distressing physical symptoms can be more easily managed. Constipation was one symptom that was less prevalent (23%) but was highly distressing for more than a third (38%) of those who experienced it; vomiting was another symptom that was not prevalent (9%) but was similarly distressing to more than a third (38%) of those who experienced it. Taken together, our findings show a wider variation in symptom experience than can be explained by one dimension alone.
It was beyond the scope of this study to investigate symptom management strategies as a covariate, but these strategies would also affect selfreported symptom experience. This is likely to be most evident in reports of severity and distress, because women who attempt to mitigate their symptoms may have been perhaps more successful in reducing severity than in reducing prevalence or frequency. Although this could account for some of the mismatch between symptom prevalence and distress, another explanation could be that some symptoms are appraised as more alarming, threatening, or unexpected than others and are hence more distressing.
Symptom management strategies are likely to be implemented based on a multidimensional appraisal of the symptom experience. The middle range Theory of Symptom Management holds that individual perception and appraisal of symptoms includes not only symptom dimensions, but person, environment, and health factors as well (Humphreys et al., 2014) . The data from this study support this notion, because there were significant differences in symptom experience based on ethnicity and level of education. There have been few recent studies of symptom evolution by trimester of pregnancy and none that define the prevalence of a symptom necessary to categorize it as common. It is not clear what threshold of tolerability would be acceptable for a pregnant woman as she appraises the need to seek relief strategies for her symptoms, and this threshold likely varies by her prior experience with health and illness or her environment. Neither is it well understood to what degree women are adequately informed about the range of expected or unexpected symptoms, or which common or expected symptoms may be associated with developing pathology, even if they are not appraised as distressful or requiring relief. For example, nearly half (46%) endorsed feeling sad on the MSAS, with frequency (27%), severity (22%), and distress (28%) similar to rates reported for other frequencybased depression measures (Edinburgh Postnatal Depression Scale) during pregnancy (Kuo et al., 2014; A. M. Lee et al., 2007) . In a Swedish sample of more than 260 women at 36 weeks gestation, 18% had Edinburgh Postnatal Depression Scale scores greater than 10 (Iliadis et al., 2015) . Severe depression during the third trimester has been reported at a rate of 7.8% when a more stringent cutpoint score of 14 for the Edinburgh Postnatal Depression Scale was used (Lau, Wong, & Chan, 2010) . Given the current clinical and media emphasis on assessment of risk for perinatal depression, to determine the critical component (frequency, severity, and/or distress) for psychopathology is crucial. Similar to physical symptoms, psychological symptoms should be assessed at antenatal clinical visits, and intervention may be necessary regardless of whether it is appraised as distressful.
The use of the MSAS, a symptom assessment tool originally developed for patient populations with cancer and used in other chronic illness populations, showed expected and unexpected findings in our study sample. Pregnant women experience symptoms that would be considered
The strong relationship between physical and psychological symptoms in late pregnancy has implications for clinicians planning interventions for symptom relief.
Beebe, K. R., Gay, C. L., Richoux, S. E., and Lee, K. A. pathologic in the nonpregnant population; therefore, using a measure of symptoms that includes a wide variety of physical and affective perceptions allowed women to identify sensations not typically attributed to pregnancy. The finding that at least one participant reported experiencing each of the 32 symptoms on the MSAS permitted identification and analyses of more and less common ones. In addition, this measure allowed an evaluation of the multidimensional nature of symptom experience. However, there was evidence that the MSAS could be modified for improved application in an obstetric population.
For example, problems with urination was only experienced by 10% of respondents, despite well-documented reports of increased urinary frequency with advancing pregnancy (Aslan, Aslan, Yamazhan, Ispahi, & Tinar, 2003) . It is possible that participants in this study did not perceive their increased urinary frequency as a problem with urination. The wording of this item may be more relevant to cancer patients for whom the MSAS was originally developed than for healthy pregnant women. The absence of specific types of pain experiences understood to be common in late pregnancy, such as leg cramps, Braxton-Hicks contractions, and lumbopelvic pain or pressure (Clark, Carr, & Way, 2013; Supakatisant & Phupong, 2015) , was not surprising given the general question structure of the MSAS; types of pain should be better described in future studies with pregnant women and other patient populations. Finally, the addition of items related to sleep and restless legs syndrome created more specificity for pregnancy symptoms, especially with regard to the item about midsleep awakenings.
Symptom experience did not differ by most demographic variables. There was an expected inverse relationship between level of education and psychological symptom scores, and significant differences by ethnicity, even in our small sample of diverse women. This may reflect better knowledge or understanding of expected symptoms, differences in symptom appraisal patterns, or more knowledge about and access to effective management strategies. In addition to differences in measures and cutpoints, ethnic/ racial differences may explain the wide prevalence ranges reported for symptoms such as anxiety and depression. Symptom experience was not associated with the sex or birth weight of the newborn.
Gestational weight gain rather than BMI was found to be positively associated with total symptom score and psychological, but not physical, symptoms. This was consistent with the findings of an older study (Tulman et al., 1998) but was contradicted by authors of a more recent investigation (Denison et al., 2009) , which focused only on BMI. Gestational weight gain, rather than absolute BMI, may be a confounding variable in other reported prevalence rates for symptoms such as depression and anxiety. With our finding that gestational weight gain is predictive of overall symptom prevalence and severity in this study, we reinforce the need for interventions designed to promote the Institute of Medicine's (2009) pregnancy weight gain recommendations. The correlations were small, which indicates that other factors not measured in this study are also likely involved in gestational weight gain, and more comprehensive interventions are warranted.
Limitations
This study had several limitations that need to be considered. The MSAS was not designed to assess symptoms during pregnancy and, thus, may not include all of the symptoms experienced by pregnant women. A number of women wrote in additional symptoms such as back pain, abdominal discomfort, heartburn, and leg cramps, which suggests that these symptoms also merit evaluation. In addition, this study's focus on a single assessment of symptoms during late pregnancy did not allow us to determine whether these symptoms were specific to late pregnancy, when these symptoms started, and whether they persisted into the postpartum period. However, the significant correlations noted among the MSAS and other validated measures of symptom experience (sleep disturbance, depression symptoms, and anxiety) during pregnancy strengthen the validity of the use of the measure in this population. Gestational weight gain was assessed retrospectively during a postpartum interview, so these data may have been affected by recall bias, although the interviews were conducted within a few weeks after birthing, and memory for such information is likely to be intact. This study was conducted from 2004 through 2008 on a population of low-risk and predominantly low-income nulliparous women, and thus, the findings cannot be generalized to other groups of women and may not reflect the symptom experience of pregnant women in more 
Implications
The strong relationship between the physical and psychological subscales of the MSAS in this sample of women reinforces the relationships between somatic and affective experiences and offers implications for clinicians planning effective packages of support for symptom relief in late pregnancy. A multidimensional approach to the reduction of one symptom may provide relief for other symptoms. For example, targeted interventions to improve sleep may have a positive effect on other physical and psychological symptoms such as anxiety, fatigue, and libido.
Further implications from these findings include the need for more research into the complexities of the symptom experience and its evolution in expectant women. Development of a validated tool to evaluate multiple dimensions of symptom experience would enhance future research into effective symptom management strategies and also aid clinicians in the evaluation of a woman's symptom patterns.
Clinical implications for nurses who provide care for women throughout pregnancy include trimester-specific teaching of common and rare symptoms. Taking the time to solicit the woman's full range of symptom experiences via multidimensional assessments will improve targeted strategies for alleviation and early identification of potential disorders. Health care providers should continue to inquire into established expectations of common versus rare and minor versus significant symptoms to provide comprehensive and individualized support to women who experience a unique variety and combination of pregnancyrelated sensations.
Conclusion
Nulliparous women experience a broad range of physical and psychological symptoms during late pregnancy. Symptoms are perceived as variably distressing, and this variability is not necessarily due to frequency alone. Excessive weight gain during pregnancy results in increased symptom frequency, severity, and distress compared with recommended or lower-than-recommended weight gain patterns. Physical and psychological symptom experience is intercorrelated and therefore well suited to interdisciplinary management, with nurses coordinating effective approaches to care.
